MiR-29b-3p promotes particulate matter-induced inflammatory responses by regulating the C1QTNF6/AMPK pathway

Jian Wang1, Mengchan Zhu1, Ling Ye1

  • 1Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai 200030, China.

Aging
|January 20, 2020
PubMed

Insights

Particulate matter exposure triggers inflammation in respiratory diseases. This study reveals miR-29b-3p promotes this inflammation by targeting C1QTNF6 and inhibiting the AMPK pathway, offering new therapeutic insights.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Immunology

Background:

  • Particulate matter (PM) exposure is a major driver of chronic respiratory diseases, primarily through inflammatory mechanisms.
  • The specific role of microRNAs (miRNAs), like miR-29b-3p, in PM-induced inflammation remained largely unexplored.

Purpose of the Study:

  • To investigate the role of miR-29b-3p in particulate matter-induced inflammatory responses in the respiratory system.
  • To elucidate the molecular mechanism by which miR-29b-3p influences PM-induced inflammation.

Main Methods:

  • Utilized miRNA PCR array to identify upregulated miRNAs in human bronchial epithelial cells (HBECs) exposed to PM.
  • Employed RNA sequencing and luciferase reporter assays to identify miR-29b-3p targets.
  • Administered miR-29b-3p antagomirs in a mouse model of PM exposure for in vivo validation.

Main Results:

  • miR-29b-3p was significantly upregulated in PM-exposed HBECs and promoted pro-inflammatory cytokine (IL-1β, IL-6, IL-8) expression.
  • miR-29b-3p targets C1QTNF6, a protein that normally activates the AMPK pathway to protect against PM-induced inflammation.
  • In vivo inhibition of miR-29b-3p counteracted PM-induced inflammation, cytokine release, and inflammatory cell infiltration in mouse lungs.

Conclusions:

  • miR-29b-3p acts as a novel pro-inflammatory regulator in particulate matter exposure.
  • The miR-29b-3p/C1QTNF6/AMPK signaling pathway is a critical mechanism in PM-induced respiratory inflammation.
  • Targeting miR-29b-3p presents a potential therapeutic strategy for mitigating adverse respiratory health effects of PM exposure.